Considerations in patients undergoing implantation of a biventricular pacemaker

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 16, Issue 2, 2002, Pages 175-179

  Lehmann, Andreas ^a   Lang, Johannes ^a   Thaler, Elfi ^a   Zeitler, Christine ^a   Weisse, Udo ^a   Boldt, Joachim ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Anesthesia; Biventricular pacing; Chronic heart failure

Indexed keywords

PROPOFOL; REMIFENTANIL;

ADULT; AGED; ANESTHESIA; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; DEFIBRILLATOR; DRUG SAFETY; EXTUBATION; FEMALE; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE PERFORMANCE; HEART VENTRICLE PACING; HEART WORK; HEMODYNAMICS; HUMAN; LUNG CAPILLARY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; OXYGEN CONSUMPTION; OXYGENATION; PATIENT SELECTION; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0036247461     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2002.31059     Document Type: Article

References (26)

1. Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure
2. The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: Rationale, design, and endpoints of a prospective, randomized, multicenter study
3. Biventricular pacing in patients with congestive heart failure: Two prospective randomized trials
4. Multisite pacing as a supplemental treatment of congestive heart failure: Preliminary results of the Medtronic Inc. InSync Study
5. Multisite pacing for end-stage heart failure: Early experience
6. What is the role of pacing in dilated cardiomyopathy?
7. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation
8. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins
9. Left ventricular lead insertion using a modified transseptal catheterization technique: A totally endocardial approach for permanent biventricular pacing in end-stage heart failure
10. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure
11. Endocardial biventricular pacing
12. Total intravenous anesthesia with remifentanil and propofoI for implantation of cardioverterdefibrillators in patients with severely reduced left ventricular function
13. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery
14. Remifentanil pharmacokinetics and pharmacodynamics: A preliminary appraisal
15. Histamine concentrations and hemodynamic responses after remifentanil
16. Remifentanil: A new opioid
17. Early extubation after mitral valve surgery: A target-controlled infusion of propofol and low-dose sufentanil
18. Hemodynamic effects, myocardial ischemia, and timing of tracheal extubation with propofol-based anesthesia for cardiac surgery
19. Comparison of the use of a propofol infusion in cardiac surgical patients with normal and low cardiac output states
20. Pharmacodynamic interaction between propofol and alfentanil when given for induction of anesthesia
21. Severe cardiovascular depression with remifentanil
22. Dynamic cardiomyoplasty in patients with end-stage heart failure: Anaesthetic considerations
23. Latissimus dorsi cardiomyoplasty: Perioperative management and postoperative evolution
24. Dynamic cardiomyoplasty: Anesthetic management
25. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients
26. Ventricular contraction abnormalities in dilated cardiomyopathy: Effect of biventricular pacing to correct interventricular dyssynchrony